Eton Pharmaceuticals, Inc. Interest and Other Income
Eton Pharmaceuticals, Inc. (ETON) reported Interest and Other Income of $281.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2020-03-05
- Eton Pharmaceuticals, Inc. interest and other income for the quarter ending 2019-12-31 was -$40.00K, a 148.78% decline year-over-year.
- Eton Pharmaceuticals, Inc. interest and other income for the quarter ending 2019-09-30 was $77.00K, a 208.00% increase year-over-year.
- Eton Pharmaceuticals, Inc. interest and other income for the quarter ending 2019-06-30 was $100.00K, a 257.14% increase year-over-year.
- Eton Pharmaceuticals, Inc. interest and other income for the quarter ending 2019-03-31 was $144.00K, a 396.55% increase year-over-year.
- Eton Pharmaceuticals, Inc. interest and other income for fiscal 2019 was $281.00K, a 71.34% increase from fiscal 2018.
- Eton Pharmaceuticals, Inc. interest and other income for fiscal 2018 was $164.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 5 month | Interest and Other Income 6 month | Interest and Other Income 8 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|---|---|
| 2019-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $37.00K derived: sum of 2 quarters · filed 2020-03-05 | $137.00K derived: sum of 3 quarters · filed 2020-03-05 | $281.00K 10-K · filed 2020-03-05 | ||
| 2019-09-30 | $77.00K 10-Q · filed 2019-11-14 | $177.00K derived: sum of 2 quarters · filed 2019-11-14 | $321.00K 10-Q · filed 2019-11-14 | $403.00K derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-06 | $244.00K 10-Q · filed 2019-08-06 | $326.00K derived: sum of 3 quarters · filed 2020-03-05 | $351.00K derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2019-03-31 | $144.00K 10-Q · filed 2019-05-07 | $226.00K derived: sum of 2 quarters · filed 2020-03-05 | $251.00K derived: sum of 3 quarters · filed 2020-03-05 | $279.00K derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2018-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $107.00K derived: sum of 2 quarters · filed 2020-03-05 | $135.00K derived: sum of 3 quarters · filed 2020-03-05 | $164.00K 10-K · filed 2020-03-05 | ||
| 2018-09-30 | $25.00K 10-Q · filed 2019-11-14 | $53.00K derived: sum of 2 quarters · filed 2019-11-14 | $82.00K 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | $28.00K 10-Q · filed 2019-08-06 | $57.00K 10-Q · filed 2019-08-06 | ||||
| 2018-03-31 | $29.00K 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | $35.00K 10-K · filed 2020-03-05 | |||||
| 2017-09-30 | $9.00K 10-Q · filed 2018-12-20 | $9.00K 10-Q · filed 2018-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |